PMID- 20948872
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20110714
LR  - 20211020
IS  - 1757-5931 (Electronic)
IS  - 1757-5931 (Linking)
VI  - 2
DP  - 2010 Feb 24
TI  - Genetic screening for multiple endocrine neoplasia syndrome type 1 (MEN-1): when 
      and how.
LID - 14 [pii]
LID - 10.3410/M2-14 [doi]
AB  - Multiple endocrine neoplasia syndrome type 1 (MEN1) syndrome has benefited from 
      the identification of the gene whose mutations account for the genetic 
      susceptibility to develop endocrine tumors. Asymptomatic MEN1 mutant carriers 
      need to be clearly recognized because the gene-related mutations confer a high 
      risk of multiple primary cancers, occur at younger ages, and affect multiple 
      family members who inherit the cancer-predisposing genetic mutation.
FAU - Falchetti, Alberto
AU  - Falchetti A
AD  - Department of Internal Medicine, University of Florence and Regional Centre for 
      Hereditary Endocrine Tumors, Unit of Metabolic Bone Diseases, University Hospital 
      of Careggi Viale G Pieraccini 6, 50139 Florence Italy.
LA  - eng
PT  - Journal Article
DEP - 20100224
PL  - England
TA  - F1000 Med Rep
JT  - F1000 medicine reports
JID - 101506841
PMC - PMC2948394
EDAT- 2010/10/16 06:00
MHDA- 2010/10/16 06:01
PMCR- 2010/02/24
CRDT- 2010/10/16 06:00
PHST- 2010/10/16 06:00 [entrez]
PHST- 2010/10/16 06:00 [pubmed]
PHST- 2010/10/16 06:01 [medline]
PHST- 2010/02/24 00:00 [pmc-release]
AID - 14 [pii]
AID - 10.3410/M2-14 [doi]
PST - epublish
SO  - F1000 Med Rep. 2010 Feb 24;2:14. doi: 10.3410/M2-14.